Lixiong Gao

Dr. Lixiong Gao


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Experimental Eye Research
Verified
Journal Article
Closed access
LGLixiong Gao
Lixiong Gao
XCXi Chen
Xi Chen
YTYongping Tang
Yongping Tang
JZJinghui Zhao
Jinghui Zhao
QLQiyou Li
Qiyou Li
ZYZheng Qin Yin
Zheng Qin Yin

18 June 2016 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
NJNi Jin
Ni Jin
LGLixiong Gao
Lixiong Gao
XFXiaotang Fan
Xiaotang Fan
HXHaiwei Xu
Haiwei Xu

11 July 2019 in BioMed Research International
Verified
Journal Article
Open access
LGLixiong Gao
Lixiong Gao
WSWeiyang Shao
Weiyang Shao
NLNa Li
Na Li
CTChunyu Tian
Chunyu Tian
HJHongzhen Jia
Hongzhen Jia
QSQian Shi
Qian Shi
Currently, the use of assisted reproductive technology (ART) is increasing. Because of the poor prognosis of retinopathy of prematurity (ROP), the association between ART and the ROP has been explored in several studies, but the result was still inconclusive. Conducting a meta-analysis, we evaluated the risk of ROP in relation to the ART. Subgroup analysis as well as groups with different embryo numbers and different ROP stages was further analyzed. The PubMed, Embase, and Cochrane Library databases were searched for studies recording data about both the use of ART and ROP occurrence simultaneously. Odds ratios (ORs) and 95% confidence interval (95%CI) were calculated to analyze the association by using random- or fixed-effect models based on heterogeneity test. In total 15 observational studies containing 10392 ART cases and 39474 spontaneous conception cases were included. Results showed that there was a significant association between the use of ART and ROP occurrence in the offspring (OR = 1.34, 95% CI: 1.05 to 1.73, P = 0.02). With subgroup analysis, we found that the influence actually came from a subgroup of ART, the in vitro fertilization (IVF). Moreover, there was a significant association between ART and ROP in singletons. Though insignificant, the ORs were larger than 1 in the analysis between ART and stage 1 and 2 ROP. But ART showed significant association with stage 3 ROP. Our study preliminarily indicated that the use of IVF was associated with higher risk of ROP occurrence. And ART is more likely to result in severe ROP and ROP in singletons. Further specific, high-quality studies with large sample size are still needed to draw more precise conclusion.

8 January 2019 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
LGLixiong Gao
Lixiong Gao
LZLijun Zhou
Lijun Zhou
CTChunyu Tian
Chunyu Tian
NLNa Li
Na Li
WSWeiyang Shao
Weiyang Shao
QSQian Shi
Qian Shi
Retinal vein occlusion (RVO) is a common retinal venous disorder that causes vision loss. No specific therapy has been developed. Controversy exists regarding two treatments: intravitreal dexamethasone implants and anti-vascular endothelial growth factor (VEGF). The goal of this study is to compare the effectiveness and safety of dexamethasone implants and anti-VEGF treatment for RVO. The PubMed, Embase, and Cochrane Library databases were searched for studies comparing dexamethasone implants with anti-VEGF in patients with RVO. Best-corrected visual acuity (BCVA), central subfield thickness (CST), intraocular pressure changes, conjunctival haemorrhage, reduced VA, and macular oedema were extracted from the final included studies. RevMan 5.3 was used to conduct the quantitative analysis and bias assessment. Four randomised controlled trials assessing 969 eyes were included. The anti-VEGF treatment showed better BCVA improvement (mean difference [MD] = − 10.59, P < 0.00001) and more CST decrease (MD = − 86.71 μm, P = 0.02) than the dexamethasone implants. However, the dexamethasone implants required fewer injections. As for adverse effects, the dexamethasone implants showed significantly higher intraocular pressure (IOP) and more cataracts than the anti-VEGF treatment. No significant differences were found in conjunctival haemorrhage, reduced VA, and macular oedema. Anti-VEGF treatment showed better functional and anatomical improvement with less risk of IOP elevation and cataract formation compared to dexamethasone implants. Thus, anti-VEGF treatment is the first choice for treating RVO patients.

13 December 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
NJNi Jin
Ni Jin
WSWeiwei Sha
Weiwei Sha
LGLixiong Gao
Lixiong Gao
Retinal degenerative disease (RDD) refers to a group of diseases with retinal degeneration that cause vision loss and affect people’s daily lives. Various therapies have been proposed, among which stem cell therapy (SCT) holds great promise for the treatment of RDDs. Microglia are immune cells in the retina that have two activation phenotypes, namely, pro-inflammatory M1 and anti-inflammatory M2 phenotypes. These cells play an important role in the pathological progression of RDDs, especially in terms of retinal inflammation. Recent studies have extensively investigated the therapeutic potential of stem cell therapy in treating RDDs, including the immunomodulatory effects targeting microglia. In this review, we substantially summarized the characteristics of RDDs and microglia, discussed the microglial changes and phenotypic transformation of M1 microglia to M2 microglia after SCT, and proposed future directions for SCT in treating RDDs.

16 November 2025 in Experimental Eye Research
Verified
Journal Article
Open access
YLYaohong Liu
Yaohong Liu
LGLixiong Gao
Lixiong Gao
WCWenqian Chen
Wenqian Chen
LLLiqin Li
Liqin Li
TMTengfei Mao
Tengfei Mao
ZLZhaohui Li
Zhaohui Li
As the only output elements and projection neurons of the retina, the degeneration and death of retinal ganglion cells (RGCs) are key indicators of various optic nerve diseases affecting millions of people worldwide. During the embryonic development of the retina, oxygen (O2) levels in the internal environment play a crucial role in the differentiation, migration, and maturation of RGCs. This article summarizes the impact of O2 on RGC fate and its underlying mechanisms, based on the developmental temporal window of RGCs. It also compares the efficacy of commonly used animal models and human organoid models in simulating in vivo retinal development. Finally, the article emphasizes the importance of utilizing advanced techniques such as microfluidics and organoid chips in models to regulate O2 levels more precisely. Additionally, combining traditional techniques like genetic perturbation and cell imaging with new technologies such as single-cell transcriptomics and CRISPR/Cas9 genome editing can enhance the depth of mechanism studies.